- Scrip
- >>Approvals & Launches
Dr. Reddy's Launches First Generic Suboxone Film; Indivior May Seek Injunction
Launch comes immediately after FDA approval of Dr. Reddy's and Mylan ANDAs while Indivior appeals district court ruling of non-infringement; Mylan settlement may delay its entry.
Indivior PLC is looking to ward off the impact of FDA's approval of generic versions of its Suboxone sublingual film (buprenorphine/naltrexone).
The company said it is considering seeking an injunction to stop Dr. Reddy's Laboratories Ltd. "at-risk" launch of the...